Cibc Bancorp Usa Inc. Glaukos Corp Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 5,961 shares of GKOS stock, worth $535,834. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,961Holding current value
$535,834% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
330Shares Held
54MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$723 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$292 Million0.06% of portfolio
-
Primecap Management CO Pasadena, CA2.25MShares$203 Million0.15% of portfolio
-
State Street Corp Boston, MA2.09MShares$188 Million0.01% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.28B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...